Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Master Protocol for Mantle Cell Lymphoma A Multicenter Phase II Trial Testing Gemcitabine for the Treatment of Patients With Newly Diagnosed, Relapsed or Chemotherapy Resistant Mantle Cell Lymphoma

NCT00234026 is registered in ClinicalTrials.gov with Swiss Cancer Institute as lead sponsor.

NCT NCT00234026
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00234026 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Master Protocol for Mantle Cell Lymphoma A Multicenter Phase II Trial Testing Gemcitabine for the Treatment of Patients With Newly Diagnosed, Relapsed or Chemotherapy Resistant Mantle Cell Lymphoma
Lead sponsor
Swiss Cancer Institute
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2005
Completion date
March 31, 2006
Enrollment
Not reported
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma